760 Bring-up beta-blockers implementation program in out-patient with heart failure. A national educational project

June 2005
European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p171
Academic Journal
An abstract of the study "Bring-Up Beta-Blockers Implementation Program in Out-Patient With Heart Failure. A National Educational Project," by M. Porcu et al. is presented.


Related Articles

  • 647 QT interval dispersion and left bundle branch block and are independent prognostic predictors in patients with chronic heart failure treated with betablocker.  // European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p152 

    An abstract of the study "QT Interval Dispersion and Left Bundle Branch Block and Are Independent Prognostic Predictors in Patients With Chronic Heart Failure Treated With Betablocker," by D. C. Albuquerque et al. is presented.

  • A cutoff point for peak VO2 with beta-blocker therapy in heart failure patients. Guimaraes, G.V.; Davila, V.M.; Silva, M.S.; Ferreira, S.A.; Bacal, F.; Bocchi, E.A. // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 1, p74 

    An abstract of the article "A cutoff point for peak VO2 with beta-blocker therapy in heart failure patients," G.V. Guimaraes and colleagues is presented.

  • Beta blockers vs. newer glaucoma agents: How do the pieces fit? Mundorf, Thomas K. // Ophthalmology Times;09/01/97 Supplement, Vol. 22 Issue 17, p2 

    Presents a transcript of the roundtable discussion on the changing role of beta blockers as first line therapy in the management of open-angle glaucoma at the 1997 meeting of the Association for Research in Vision and Ophthalmology. Improvements on nonselective beta blockers; Safeness of the...

  • Beta-blockers after MI: Seriously underused. Pinkowish, Mary Desmond // Patient Care;2/28/1997, Vol. 31 Issue 4, p29 

    Cites the findings of a study on the use of beta-blockers in postmyocardial infarction therapy in the United States. Beneficial effects of beta-blockers in postmyocardial infarction therapy; Underusage of beta-blockers in postmyocardial infarction therapy; Recommendation to avoid adverse...

  • Treatment of Thyrotoxic Storm with Intravenous Administration of Propranolol. Das, Gopal; Krieger, Michael // Annals of Internal Medicine;May69, Vol. 70 Issue 5, p985 

    Describes the case of a thyrotoxic storm which was refractory to conventional therapy but responded immediately to beta adrenergic blockade by means of intravenous administration of propranolol. Medical history of the patient studied; Symptoms reported by the patient; Factor attributed to the...

  • Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers. Steinert, J.; Pugh, C.R. // British Medical Journal;3/24/1979, Vol. 1 Issue 6166, p790 

    Focuses on patients suffering from psychotic illness during treatment with beta-adrenergic blockers in London, England. Use of the drug for cardiovascular illness; Emphasis on the dosage of the drug; Improvement on the neuroleptic medications.

  • Utility of antimuscarinic drugs. Wolstenholme, Roger J. // BMJ: British Medical Journal;2/1/2014, Vol. 348 Issue 7943, p23 

    A letter to the editor is presented in response to the article "Effect of ß Blockers on Mortality After Myocardial Infarction in Adults With COPD: Population Based Cohort study of UK Electronic Healthcare Records," by JK Quint and colleagues in the November 22, 2013 issue.

  • Why Aren't We Using Beta Blockers After Acute MI? Weichel, Amy S. // American Family Physician;10/15/2000, Vol. 62 Issue 8, p1771 

    Editorial. Highlights the underutilization of therapy with beta blockers after acute myocardial infarction (MI). Effectiveness of beta blockers in reducing mortality after acute MI; Categorization of interventions based on effectiveness in promoting behavior changes in physicians.

  • Topical, systemic beta-blockers don't work together. Guttman, Cheryl; Schuman, Joel S. // Ophthalmology Times;04/15/2000, Vol. 25 Issue 8, p80 

    Presents information on a study which investigated the interaction between topical and systemic beta-blockers for the treatment of ocular hypertension or glaucoma. Efficacy of brimonidine as an intraocular pressure-lowering treatment; Pharmacodynamic interaction between topical and systemic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics